Use of intravenous and oral sodium thiosulfate for acute treatment and chronic management of nonuremic calciphylaxis: A retrospective case series
Open Access
- 6 February 2026
- journal article
- case report
- Published by Elsevier in JAAD Case Reports
- Vol. 71, 161-166
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- State Policies and Facility Practices of IV Hydration Spas in the USJAMA Internal Medicine, 2025
- IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxisNature Reviews Nephrology, 2025
- Outcomes and mortality in calciphylaxis: A multicenter updateJournal of the American Academy of Dermatology, 2025
- Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extensioneClinicalMedicine, 2024
- Intravenous Sodium Thiosulphate for Calciphylaxis of Chronic Kidney DiseaseJAMA Network Open, 2023
- Manifestation of Nonuremic Calciphylaxis in the Extremities: Case Report and ReviewThe Journal of Foot and Ankle Surgery, 2022
- Calciphylaxis in uraemic and nonuraemic settings: clinical risk factors and histopathological findingsClinical and Experimental Dermatology, 2021
- CalciphylaxisNew England Journal of Medicine, 2018
- Warfarin-Associated Nonuremic CalciphylaxisJAMA Dermatology, 2017
- Sodium thiosulfate in the treatment of non‐uremic calciphylaxisThe Journal of Dermatology, 2013